Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014743 |
| CAS No | NA |
| Mol.F. | C24H29N3O4 |
| Mol.Wt. | 423.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014744 |
| CAS No | NA |
| Mol.F. | C31H33N3O4 |
| Mol.Wt. | 511.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014745 |
| CAS No | 937-23-5 |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.04 |
| INV STATUS | In Stock |
| CAT No | SRC-N014746 |
| CAS No | NA |
| Mol.F. | C20H22FN5O3 |
| Mol.Wt. | 399.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014747 |
| CAS No | NA |
| Mol.F. | C18H27N3O5 |
| Mol.Wt. | 365.42 |
| INV STATUS | In Stock |
| CAT No | SRC-N014748 |
| CAS No | NA |
| Mol.F. | C22H21N7O2 |
| Mol.Wt. | 415.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014749 |
| CAS No | NA |
| Mol.F. | CH3N3O2 |
| Mol.Wt. | 89.05 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014750 |
| CAS No | NA |
| Mol.F. | C20H18D3N9O4 |
| Mol.Wt. | 454.47 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014751 |
| CAS No | NA |
| Mol.F. | C21H31Cl2N5O2 |
| Mol.Wt. | 456.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014752 |
| CAS No | NA |
| Mol.F. | C20H24N2O2 |
| Mol.Wt. | 324.40 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014753 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014754 |
| CAS No | NA |
| Mol.F. | C14H10N2O2 |
| Mol.Wt. | 238.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014755 |
| CAS No | NA |
| Mol.F. | C15H12N2O2 |
| Mol.Wt. | 252.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014756 |
| CAS No | NA |
| Mol.F. | C14H8N2O3 |
| Mol.Wt. | 252.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014757 |
| CAS No | NA |
| Mol.F. | C24H26N6O3 |
| Mol.Wt. | 446.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014758 |
| CAS No | NA |
| Mol.F. | C24H26N6O3 |
| Mol.Wt. | 446.5 |
| INV STATUS | UNDER SYNTHESIS |